Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARNI-VAL Type I: Valproic Acid and Carnitine in SMA Type I
NCT00661453Phase 2Completed
- Sponsor
- University of Utah
- Start
- Apr 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in spinal muscular atrophy type 1 (SMA1), sponsored by University of Utah. Primary endpoints: Laboratory Safety Data at 6 months and Anthropometric Measures of Nutritional Status at 6 months. Started Apr 2008; status: completed.
02
Drugs
valproic acid
03
Conditions
spinal muscular atrophy type 1 (SMA1)
Beyond the preview
Go deeper on NCT00661453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661453.